ment, using recent births drawn from a Census-based sampling frame; of these women, 6,421 completed enough of the questionnaire to be considered respondents for the MES study cohort. Each responding woman was assigned a sampling weight calculated within weighting classes, which generally corresponded to the strata used to draw the sample. Additional post-strata information based on the mother's first language and Aboriginal status was also used. The 6,421 respondents were thus weighted to represent 76,508 women, which is considered a nationally representative sample.
Women were considered to be knowledgeable if they reported "yes" to the question "before your pregnancy, did you know that taking folic acid before pregnancy can help prevent some birth defects?" Women were categorized into two groups according to their FA supplementation: "met recommended guidelines", meaning they reported "yes" to all of the following questions: "In the 3 months before you got pregnant, did you take a multivitamin containing folic acid or a folic acid supplement?", "Did you take it every day?", "During the first 3 months of your pregnancy, did you take a multivitamin containing folic acid or a folic acid supplement?", and "Did you take it every day?"; or, "did not meet the recommended guidelines". Socio-demographic characteristics included self-reported age (in years), marital status, education, ethnicity, province/territory of residence, employment status, and country of birth (of mothers). A variable labelled low income cut-off (LICO) was derived using a set of criteria used by Statistics Canada that help identify an income threshold below which a family will likely devote a larger share of its income on the necessities of food, shelter and clothing than the average family in Canada. This was dichotomized as "at/below LICO" and "above LICO". Marital status categories included: single/never married, married, living common-law, divorced, separated, widowed, and refused. Education was based on the highest level of formal education completed and was grouped as: less than high school, completed high school and some post-secondary, post-secondary and university degree. Pregnancy-related characteristics included parity (primiparous/multiparous), pre-pregnancy smoking status (no smoking/occasionally/daily), time to first prenatal care visit (in first trimester/after first trimester), any pre-existing health issues and planned or unplanned pregnancy. Planned and unplanned pregnancy was determined by a proxy question: "Thinking back to just before you became pregnant, would you say that you wanted to be pregnant..?" If women answered "later" or "not at all", they were considered to have had an unplanned pregnancy, and if women responded "sooner" or "then", they were considered to have had a planned pregnancy.
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Data were analyzed using SPSS software for Windows, version 16.0. 5 The statistical significance of crude comparisons of proportions was assessed using chi-squared tests (p<0.05). Logistic regression was used to calculate univariate and multivariate odds ratios; variance and 95% CI for various risk factors in relation to both awareness and use of FA were calculated using 1,000 replicate bootstrap weights. The models were adjusted for all socio-demographic and pregnancy-related factors.
RESULTS
Demographics
The weighted sample consisted of 76,508 women (based on 6,421 survey respondents). The majority of women were aged 25-29 years of age (33.1%), followed by 30-34 (32.9%). Most of the women had post-secondary diplomas (37.0%) or were university graduates (31.0%) and were above LICO (72.6%). Over half the sample had already experienced a pregnancy (54.9%), while the other women were first-time mothers (44.7%).
Folic acid awareness
Overall, 77.6% of women surveyed were aware of the benefits of taking FA before pregnancy. Awareness increased with age, as knowledgeable women represented 32.3% of those aged 15-19 and 77.4% of those aged 25-29, compared to the highest frequencies of awareness, which were seen in the 30-34 (87.0%) and the 45-49 (92.9%) age groups (Table 1) .
With respect to geographical variation, levels of awareness ranged from 83.9% to 35.1% nationally (p<0.001), with women in the Yukon, Nova Scotia, and Newfoundland reporting the highest levels, whereas women living in Nunavut and the Northwest Territories were the least knowledgeable.
There were statistically significant socio-economic differences (p<0.001) in knowledge among women with less than high school education, single women and women living at or below the LICO compared to women with a university degree, married and living above the LICO.
Aboriginal women were less likely to report awareness of FA compared to non-Aboriginal women (51.5% versus 79.6%, p<0.001). Women who reported having an unplanned pregnancy were less likely to report awareness of the benefits of FA than women who had a planned pregnancy (63.1% versus 83.0%, p<0.001), even after controlling for age, income, education and other variables (AOR 0.6; CI 0.50-0.71).
Folic acid use
Overall, 57.7% of women reported taking a multivitamin containing FA and FA supplementation prior to becoming pregnant. Of these, 90% of women who reported taking a multivitamin or supplement took it every day. Table 2 .
Folic acid use in preconception and first three months of pregnancy in relation to selected factors The majority of women, 89.4%, reported taking FA (multivitamin or supplement) during the first three months of pregnancy, 92.2% of whom took it every day. Women aged 15-19 were the least likely to take FA during their first three months of pregnancy (69.8%) compared to women aged 35-39 (93.5%, p<0.001).
A pattern is noted among preconception FA use, similar to the trend found in FA awareness (Table 2) . Women who had less than high school education, were high school graduates or had post-secondary education below university level were less likely to report use than those with a university degree (p<0.001). Women who reported living at or below the LICO also reported less use than those reporting being above the LICO (p<0.001). Women who were employed during their pregnancy reported higher use than those who were unemployed (p<0.001).
Provincial variations were noted in FA use prior to pregnancy and during the first trimester of pregnancy. Pre-pregnancy use ranged from 16.1% in Nunavut to 67.5% in Yukon (p<0.001). Similarly, women in Nunavut reported the least use in the first three months of pregnancy (51.5%), while women in the Yukon reported the highest rate (98.7%, p<0.001).
Non-Aboriginal women reported more FA use in pre-pregnancy and during their first trimester than Aboriginal women (58.9% versus 35.3%, and 90.1% versus 79.8%, respectively; p<0.001).
Folic acid awareness versus use
Despite their awareness of the benefits of FA, only 68.8% of knowledgeable women actually took an FA-containing supplement before Table 3 .
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Folic acid use in preconception in relation to selected factors among women who were knowledgeable of folic acid benefits becoming pregnant. After controlling for age, parity, LICO, education and other factors, there were still clear socio-economic differences among those knowledgeable women who did not use FA in the preconception period compared to those who did (Table 3) . A trend was observed between education and FA use. Women who reported having less than high school education were less likely to use FA (AOR 0.45; CI 0.33-0.62) compared to women with a university degree. This relationship was also noted between employment and reported LICO. Women who were unemployed and those who lived at or below the LICO were less likely to report FA use in comparison to women who were employed and lived above the LICO (AOR 0.49; CI 0.41-0.58). Being a first-time mother increased the likelihood of use (2.1 times (CI 1.5-3.0) more likely to use FA), even after controlling for a myriad of potential confounding variables, including unplanned pregnancy (Table 3 ). In general, among knowledgeable women, those whose pregnancies were unplanned were significantly less likely to use FA (AOR 0.19; CI 0.13-0.27).
There were statistically significant age differences among knowledgeable women who did not take FA. Women aged 15-19 (AOR 0.22; CI 0.12-0.41) and 20-24 (AOR 0.41; CI 0.32-0.52) reported less FA use prior to becoming pregnant, compared to those aged 30-34 (reference group). No significant differences were noted among women older than the reference group.
Regional differences were noted in the distribution of knowledgeable women; however, once adjusted for the potential con- founding variables, these differences were no longer significant. Nunavut reported the least FA use (AOR 0.56; CI 0.22-1.4) while women in Yukon reported the most (AOR 1.1; CI 0.56-2.0). Aboriginal women were less likely to report FA use (AOR 0.51; CI 0.38-0.68) compared to non-Aboriginal women.
Awareness versus use according to the national recommended guidelines
Although 68.8% of knowledgeable women took FA, only 49.2% of the total sample followed the national guidelines for optimal use, which include daily supplementation prior to conception and during the first three months of pregnancy. Similar to the trends noted above, there were statistically significant differences in frequency of optimal use among women aware of the benefits of FA (Table 4) With respect to any socio-demographic factor, women who made up the largest proportion of those who supplemented according to the recommended guidelines reported having a university degree (69.0%). Women with lower levels of education reported significantly less optimal use (p<0.001). Similar to the above-noted trends, women who reported living above the LICO and employed women reported optimal supplementation more than their counterparts (p<0.001).
Provincial variation also existed, even after controlling for potential confounding variables. Optimal use among knowledgeable women ranged from a low of 28.6% in Nunavut to a high of 64.7% in Yukon, with significant differences noted in Quebec (AOR 0.62; CI 0.39-0.99) and British Columbia (AOR 0.61; CI 0.41-0.92). Knowledgeable non-Aboriginal women reported more FA use according to the recommended guidelines than knowledgeable Aboriginal women (60.2% versus 39.4%, AOR 0.39; CI 0.22-0.69).
Last, knowledgeable women experiencing a first pregnancy were two times more likely to report having supplemented optimally, which resulted in the strongest predictor of ideal FA use (AOR, 2.0; CI 1.53-2.60; p<0.001), even after controlling for potential confounders, including planned pregnancy.
DISCUSSION
The data from the MES revealed that less than half of all Canadian women adhered to the national recommended guidelines for FA supplementation, including daily supplementation before conception and during the first three months of pregnancy. This study identified several maternal socio-economic factors that may influence whether women supplement optimally, if at all. Consistent with most public health literature, the data indicated that women who were under 25 years, had less than a university education and were at or below the low income cut-off score, were less likely to have knowledge of FA benefits, and were less likely to report supplement use prior to conception.
Although the majority of women in our sample understood that FA supplementation could help prevent NTDs, approximately one quarter were unaware of this information. The first Canadian guidelines for use of FA supplementation at levels of 0.4 mg/day for all low-risk women of childbearing potential were published in 1993. 6 Previous research showed that a lack of awareness of the relationship between FA and NTD and failure to use supplements subsequently remained a major problem. A survey of 123 women attending a medical genetics clinic in Montréal in 1994 documented that only 18% were aware of the association between FA and NTD, and few (18%) were taking supplements regularly. 7 A further study of 342 women attending a similar clinic in Ottawa was carried out in 1996. A high proportion of these (81%) were aware of FA, but only 26.3% had taken FA early enough before pregnancy to be effective. 7 Our results show that, although the majority of women reported knowledge of FA, the percentage who were supplementing according to national guidelines was less than 50%. Similar findings have been observed elsewhere in Canada. For example, a study done in the Chaudière-Appalaches region of Québec 8 evaluated a health promotion intervention in two phases in 1999 and 2001. The proportion of women identifying that FA was important for NTD risk reduction did increase significantly between the two phases of the project, from 62.0% (CI 95% 57.3-66.7%) to 70.9% (65.9-75.9%). However, this increase in knowledge did not translate into a marked increase in women using FA. Adequate periconceptional FA use was reported by 26.1% of women in phase 1 and by 31.6% after the intervention (p<0.05). 8 While some Canadian studies prior to the MES explored factors relating demographic and pregnancy-related factors with appropriate use of FA supplementation, few documented their impact on knowledge and fewer still did so in the context of multivariate analysis. Women's age was an important factor, with younger women -especially those under 20 years 9 -being significantly less aware. A large Slone Epidemiology Study found no relationship with age once adjustments were made for confounding factors such as education, ethnicity, income, parity and planned pregnancy. 10 Our study, however, demonstrated that age was an independent predictor of FA awareness and use, even after controlling for education, income, parity, marital status and planned pregnancy, among others.
Women's education level was an important independent variable in many studies, and knowledge, not unexpectedly, was highest among those with post-secondary qualifications and lowest among those who had not completed high school. [7] [8] [9] 11 Our study supports these findings, as a linear relationship was noted among FA use and awareness and level of education. Those with university degrees made up the largest group of women supplementing preconceptionally and according to the national recommended guidelines.
With respect to geography, the MES was the first to document knowledge across the country. Previously, rates of awareness of FA had been noted to be lower in rural areas and small cities than in large population centres, but there was considerable variation. 12 The geographic variability in both use and knowledge has been highlighted, particularly for Northern Canada. Women in Nunavut reported the least knowledge and use of FA. Furthermore, Aboriginal women reported less knowledge and use of FA compared to non-Aboriginal women in Canada. The survey did not interview Aboriginal women on reserve; therefore the results are limited by way of knowing if similar patterns exist elsewhere in Canada.
Last, although the majority of women were aware of the benefits of supplementing FA in their diets, only 57.7% of women were supplementing prior to becoming pregnant and less than half of all women were supplementing according to the Canadian recom-mended guidelines. As all women were interviewed postpartum, there may be recall issues in terms of knowledge of folic acid (i.e., they may have learned this information after they found out they were pregnant) or social desirability bias, as all data were self-reported (the proportion of knowledgeable women may be lower than reported).
By evaluating the characteristics of women who understood the benefits of FA, we have been able to identify several sociodemographic factors influencing the translation of this knowledge into actual supplement use. This information can be used to tailor specific interventions to target populations (i.e., younger women, Aboriginal women). However, these data indicate that knowledge alone is not enough to increase supplementation in Canadian women. An opportunity to hear women's voices may provide important messages with respect to FA supplementation and the potential approaches that could enhance its use, particularly for women who have already experienced a pregnancy.
CONCLUSIONS
This study documents findings that are consistent with other literature on FA awareness, and presents new information that can be used for public health interventions. Although most women surveyed in the MES understood the benefits of FA supplementation, a little over a third of them did not take FA supplements prior to becoming pregnant, and less than half supplemented according to national guidelines. Socio-economic factors are highlighted as potential foci for public health interventions to increase awareness and use of FA. Having a first pregnancy seems to be a predictor of supplementation, but not for subsequent pregnancies. Knowledge is still imperfect and more needs to be done to increase awareness, especially among certain population groups such as younger women and those with lower socio-economic status. Unplanned pregnancy is still a major impediment and emphasizes the need for promotion of regular and consistent use: if you can conceive, you should be taking supplements. Issues of non-compliance, such as financial barriers or concerns about the safety of FA, need to be acknowledged and addressed and form the basis for subsequent qualitative research studies.
